https://www.selleckchem.com/pr....oducts/abraxane-nab-
Although costs were higher by $28 million, the incremental cost-effectiveness ratio was $86,458, below the willingness-to-pay threshold. CONCLUSIONS For children at intermediate risk of SCD and HCM, in-home AED is cost effective, resulting in fewer deaths and increased QALYS for a cost below the willingness-to-pay threshold. These findings highlight the economic benefits of in-home AED utilization in this population. In 2012, a novel canine Dirofilaria species, D. hongkongensis was identified in Hong Kong that caused hum
Aimer
Commentaire
Partagez
